These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28235571)

  • 1. Efficacy of rifampicin combination therapy for the treatment of enterococcal infections assessed in vivo using a Galleria mellonella infection model.
    Skinner K; Sandoe JAT; Rajendran R; Ramage G; Lang S
    Int J Antimicrob Agents; 2017 Apr; 49(4):507-511. PubMed ID: 28235571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of oritavancin alone and in combination against vancomycin-susceptible and -resistant enterococci in an in-vivo Galleria mellonella survival model.
    Meyer KA; Deraedt MF; Harrington AT; Danziger LH; Wenzler E
    Int J Antimicrob Agents; 2019 Aug; 54(2):197-201. PubMed ID: 31034937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae.
    Luther MK; Arvanitis M; Mylonakis E; LaPlante KL
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4612-20. PubMed ID: 24867993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
    Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
    Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo synergism of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis assessed in the Galleria mellonella infection model.
    Thieme L; Hartung A; Makarewicz O; Pletz MW
    J Antimicrob Chemother; 2020 Aug; 75(8):2173-2181. PubMed ID: 32357212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model.
    Oliva A; Furustrand Tafin U; Maiolo EM; Jeddari S; Bétrisey B; Trampuz A
    Antimicrob Agents Chemother; 2014; 58(3):1284-93. PubMed ID: 24145537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activity of fosfomycin and chloramphenicol against vancomycin-resistant Enterococcus faecium (VREfm) isolates from bloodstream infections.
    Lagatolla C; Milic J; Imperi F; Cervoni M; Bressan R; Luzzati R; Di Bella S
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115241. PubMed ID: 33130503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic regimens with rifampicin for treatment of Enterococcus faecium in biofilms.
    Holmberg A; Rasmussen M
    Int J Antimicrob Agents; 2014 Jul; 44(1):78-80. PubMed ID: 24837415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of Rifr mutations in Enterococcus faecalis and Enterococcus faecium.
    Du X; Hua X; Qu T; Jiang Y; Zhou Z; Yu Y
    J Chemother; 2014 Aug; 26(4):217-21. PubMed ID: 24070269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
    Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
    J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.
    Elsner HA; Sobottka I; Feucht HH; Claussen M; Kaulfers PM; Laufs R; Mack D
    Chemotherapy; 2000; 46(2):104-10. PubMed ID: 10671760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Gram-positive cocci isolated from surgical wound infections.
    Simonetti O; Morroni G; Ghiselli R; Orlando F; Brenciani A; Xhuvelaj L; Provinciali M; Offidani A; Guerrieri M; Giacometti A; Cirioni O
    J Med Microbiol; 2018 Jan; 67(1):139-143. PubMed ID: 29154746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and pharmacological inactivation of d-alanylation of teichoic acids sensitizes pathogenic enterococci to β-lactams.
    Coupri D; Budin-Verneuil A; Hartke A; Benachour A; Léger L; Lequeux T; Pfund E; Verneuil N
    J Antimicrob Chemother; 2019 Nov; 74(11):3162-3169. PubMed ID: 31339997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From formulation to in vivo model: A comprehensive study of a synergistic relationship between vancomycin, carvacrol, and cuminaldehyde against Enterococcus faecium.
    Owen L; Webb JP; Green J; Smith LJ; Laird K
    Phytother Res; 2020 Jul; 34(7):1638-1649. PubMed ID: 32045500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci.
    Baltch AL; Smith RP; Ritz WJ; Bopp LH
    Chemotherapy; 2001; 47(4):250-60. PubMed ID: 11399861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the in vitro synergy of daptomycin plus linezolid against multidrug-resistant enterococci.
    Entenza JM; Giddey M; Vouillamoz J; Moreillon P; Mancini S
    J Glob Antimicrob Resist; 2014 Dec; 2(4):306-308. PubMed ID: 27873692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 May; 59(5):2842-8. PubMed ID: 25753639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.